Search
for
Sort by
Research 541–570 of 1000+
- Efficacy and safety of topical finasteride spray solution in the treatment of Chinese men with androgenetic alopecia: A phase III, multicenter, randomized, double-blind, placebo-controlled study
- CXCL12 Neutralizing Antibody Promotes Hair Growth in Androgenic Alopecia and Alopecia Areata
- Botulinum Toxin Type A Alleviates Androgenetic Alopecia by Inhibiting Apoptosis of Dermal Papilla Cells via Targeting circ_0135062/miR-506-3p/Bax Axis
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Oxyresveratrol enhances hair regeneration in human dermal papilla cell and androgenetic alopecia mouse model
- Homocysteine in androgenetic alopecia: A case control study and observational experiments on mice
- Efficacy of type A botulinum toxin treatment for androgenetic alopecia using ultrasound combined with trichoscopy
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Sex Differences in Animal Models of Sodium-Valproate-Induced Autism in Postnatal BALB/c Mice: Whole-Brain Histoarchitecture and 5-HT2A Receptor Biomarker Evidence
- The Therapeutic Response of Platelet Rich Plasma (PRP) for Androgenetic Alopecia Showed No Correlation with Growth Factors and Platelet Number
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Distribution of Body Hair in Young Australian Women and Associations With Serum Androgen Concentrations
- The mediation role of sleep on the relationship between drinks behavior and female androgenetic alopecia
- Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory Homodimerization
- A Review of Androgen‐Progestin Regimens for Male Contraception
- A proposal of an effective platelet-rich plasma protocol for the treatment of androgenetic alopecia
- Androgenetic Alopecia: Clinical Aspects and Treatment
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
- Approach to androgen excess in women: Clinical and biochemical insights
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
- Antioxidation, Anti-Inflammation, and Regulation of SRD5A Gene Expression of Oryza sativa cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances
- Androgenetic alopecia as an early marker for hypertension
- What does the research say about androgen use and cerebrovascular events?
- Antiandrogenic therapy with ciproterone acetate in female patients who suffer from both androgenetic alopecia and acne vulgaris
- Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males